Calidi Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 879.00 K | $209.91 K | 100.00% | 8.53% |
| SABBY MANAGEMENT, LLC | 05/15/2026 | 434.90 K | $103.86 K | 100.00% | 4.22% |
| WARBERG ASSET MANAGEMENT LLC | 05/07/2026 | 250.00 K | $59.48 K | 100.00% | 2.43% |
| HIGHTOWER ADVISORS, LLC | 05/05/2026 | 83.52 K | $19.95 K | 0.00% | 0.81% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 75.77 K | $18.00 K | 256.68% | 0.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 63.02 K | $15.05 K | 50.30% | 0.61% |
| RS CRUM INC. | 04/15/2026 | 40.26 K | $9.61 K | 98.74% | 0.39% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 37.35 K | $8.92 K | 100.00% | 0.36% |
| JANE STREET GROUP, LLC | 05/12/2026 | 34.80 K | $8.31 K | 202.86% | 0.34% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 25.51 K | $6.10 K | 100.00% | 0.25% |
| BELPOINTE ASSET MANAGEMENT LLC | 04/28/2026 | 19.92 K | $4.76 K | -0.25% | 0.19% |
| NORTHERN TRUST CORP | 05/14/2026 | 17.76 K | $4.24 K | 0.00% | 0.17% |
| HRT FINANCIAL LP | 05/14/2026 | 10.13 K | $2.00 K | 100.00% | 0.10% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 10.00 K | $2.43 K | 0.00% | 0.10% |
| MORGAN STANLEY | 05/15/2026 | 9.47 K | $2.26 K | 545.33% | 0.09% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 9.22 K | $2.20 K | 100.00% | 0.09% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 2.11 K | $503 | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.40 K | $333 | -49.68% | 0.01% |
| APOLLO MANAGEMENT HOLDINGS, L.P. | 05/15/2026 | 1.04 K | $249 | 0.00% | 0.01% |
| FINEPOINT CAPITAL LP | 05/14/2026 | 1.04 K | $249 | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.04 K | $248 | 100.00% | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.04 K | $248 | 0.00% | 0.01% |
| FMR LLC | 05/15/2026 | 255 | $61 | -98.84% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 115 | $27 | 150.00% | 0.00% |
| TRADEWINDS CAPITAL MANAGEMENT, LLC | 04/15/2026 | 101 | $25 | 0.00% | 0.00% |
| REYES FINANCIAL ARCHITECTURE, INC. | 05/12/2026 | 100 | $24 | 0.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 04/29/2026 | 42 | $10 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 14 | $3 | 1,300.00% | 0.00% |
| EVERMAY WEALTH MANAGEMENT LLC | 05/12/2026 | 1 | $1 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| BARRETT & COMPANY, INC. | 05/04/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Calidi Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Calidi Biotherapeutics Inc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 879,000
SABBY MANAGEMENT, LLC: 434,903
Warberg Asset Management LLC: 250,000
Virtu Financial LLC: 75,769
GEODE CAPITAL MANAGEMENT, LLC: 63,019
RS CRUM INC.: 40,256
19.49% of Calidi Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.92 M shares in the last 24 months. This purchase volume represents approximately $709.27 K in transactions.